サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1659439

粒子線治療の世界市場

Particle Therapy

出版日
ページ情報
英文 83 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
粒子線治療の世界市場
出版日: 2025年02月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 83 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

粒子線治療の世界市場は2030年までに28億米ドルに達する見込み

2024年に17億米ドルと推定される粒子線治療の世界市場は、2024年から2030年にかけてCAGR 8.8％で成長し、2030年には28億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである陽子線治療は、CAGR 9.2%を記録し、分析期間終了時には23億米ドルに達すると予測されます。重粒子線治療セグメントの成長率は、分析期間でCAGR 7.1％と推定されます。

米国市場は4億8,140万米ドルと推定、中国はCAGR8.0％で成長予測

米国の粒子線治療市場は、2024年に4億8,140万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 8.0%で推移し、2030年には4億3,210万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.3％と7.0％と予測されています。欧州では、ドイツがCAGR約7.0%で成長すると予測されています。

世界の粒子線治療市場- 主要動向と促進要因のまとめ

現代のがん治療に粒子線治療が欠かせない理由とは？

粒子線治療は、周囲の健康な組織へのダメージを最小限に抑えながら、正確でターゲットを絞った放射線治療を提供し、現代のがん治療において不可欠で非常に効果的な治療オプションとなっています。従来の光子ベースの放射線とは異なり、粒子線治療は陽子や炭素イオンなどの荷電粒子を使用するため、腫瘍医は隣接する健康な組織を温存しながら、腫瘍に直接高線量の放射線を照射することができます。この精度は、脳腫瘍、小児がん、脊髄付近の腫瘍など、重要な構造物の近くに位置するがんを治療する際に特に価値があり、健康な組織を温存することが極めて重要です。その結果、粒子線治療は、複雑で治療が困難ながんの治療の礎石となり、治療成績の大幅な改善と副作用の軽減を実現しています。

その精度に加え、粒子線治療は腫瘍部位での線量強度が高いため、従来の放射線照射に反応しにくい放射線抵抗性腫瘍に特に有効です。ブラッグピーク効果などの粒子線のユニークな特性により、腫瘍部位で直接最大のエネルギーを放出することができ、腫瘍以外への放射線被曝を減らすことができます。この利点により、副作用や長期合併症を最小限に抑えることができ、特に小児患者や敏感な臓器の近くにがんがある患者にとって有益です。患者にとって、粒子線治療は、合併症が少なく、治療期間が短縮される可能性があることを意味し、高精度のがん治療を行う現代の腫瘍学において好ましい選択肢となっています。

さらに、粒子線治療は、各患者の腫瘍の特徴に合わせた治療計画を可能にするため、個別化がん治療の増加傾向に合致しています。画像診断と治療計画の進歩により、腫瘍医は粒子線治療を使用して、腫瘍の大きさ、形状、位置に基づいて比類のない精度で腫瘍を標的にすることができ、治療効果を向上させる個別化アプローチを提供することができます。この機能により、粒子線治療はプレシジョン・オンコロジーに不可欠な存在となり、がん治療による身体的・精神的負担を軽減しながら、患者の予後を向上させる高度な標的治療のニーズに応えることができます。

技術の進歩は粒子線治療をどのように強化していますか？

技術の進歩は、粒子線治療の有効性、アクセシビリティ、効率性を著しく向上させ、がん治療への応用と魅力を広げています。この分野における最も重要な技術革新のひとつは、線量分布のさらなる精度を可能にする強度変調陽子線治療（IMPT）の開発です。IMPTによって腫瘍医は陽子ビームの強度を調節できるようになり、腫瘍の輪郭に合わせてより正確に陽子ビームを形成し、近くの健康な組織をより効果的に温存できるようになった。この高度な制御は、放射線誘発性副作用のリスクを低減し、複雑で不規則な形状の腫瘍に特に有益です。IMPT技術が進歩し続けるにつれて、課題の多いがん種の患者に対する治療成績が向上し、粒子線治療の全体的な有効性が高まっています。

リアルタイムMRIやPETスキャンなどの高度な画像技術の統合は、治療の指針となる詳細なリアルタイム画像を提供することにより、粒子線治療の精度をさらに向上させています。これらの画像技術により、腫瘍医は腫瘍の位置を正確に特定し、呼吸や患者の移動などの腫瘍の動きを考慮して治療パラメータを調整することができます。リアルタイムイメージングと粒子線治療を組み合わせることで、腫瘍医はより正確で適応的な治療を提供することができ、放射線を腫瘍に確実に照射し、周辺組織を温存することができます。この技術革新は、適応的な粒子線治療をサポートし、治療に対する腫瘍の変化に応じて治療を動的に調整し、効果を高め、副作用を最小限に抑えることを可能にします。

シングルルーム陽子線治療装置など、コンパクトで費用対効果の高い粒子線治療システムの開発により、粒子線治療の利用しやすさと価格が向上しました。従来、粒子線治療は大規模で複雑、かつ高価な施設を必要としていたため、利用できる施設は世界中の限られた施設に限られていました。しかし、小型システムの進歩により、より多くの病院やがんセンターが粒子線治療技術を採用することが可能となり、より多くの患者さんが利用できるようになりました。これらのコンパクトなシステムは、大規模なインフラの必要性を減らし、コストを大幅に削減し、地域の病院や地域のがんセンターがこの高度な治療を提供することを可能にします。粒子線治療をより手頃な価格で広く利用できるようにすることで、これらの技術的進歩はその範囲を拡大し、より多くの患者に高精度のがん治療を提供します。

粒子線治療の患者およびヘルスケアシステムにとっての利点とは？

粒子線治療は、がん治療に正確で効果的、かつ患者に優しいアプローチを提供することで、患者とヘルスケアシステムの双方に大きなメリットをもたらします。患者にとって、粒子線治療の主な利点のひとつは、健康な組織へのダメージを最小限に抑え、短期的、長期的な副作用を軽減できることです。この組織温存の特性は、合併症のリスクを軽減し、生活の質を維持するため、小児患者や繊細な構造の近くに腫瘍がある患者にとって特に価値があります。粒子線治療は、周辺組織への放射線被曝を最小限に抑えることで、副作用の少ない治療を可能にし、早期回復や治療後のQOLの向上につながります。この利点は、放射線被曝に伴う二次がんや発育上の問題のリスクを低減するため、特に若い患者にとって有益です。

ヘルスケアシステムにとって、粒子線治療は放射線による副作用や合併症の管理に伴う長期的なケアコストを削減します。従来の放射線治療では、放射線皮膚炎や臓器の損傷、さらには二次的な悪性腫瘍などの副作用を管理するために、治療後に大規模なケアが必要になることがよくありました。粒子線治療の的確なターゲティングにより、このような合併症の発生率は大幅に減少し、入院の減少やフォローアップ治療の需要の減少につながります。治療後の合併症の減少は、ヘルスケアシステムのコスト削減につながり、リソースをより効果的に配分することを可能にします。粒子線治療は、長期的な影響が少なく、より良い患者の転帰をサポートすることで、より持続可能ながん治療のアプローチに貢献し、ヘルスケアシステムに財政的、運営上の利益をもたらします。

また、粒子線治療は、個別化・精密腫瘍学へのシフトにも合致しており、ヘルスケアプロバイダーは各患者の腫瘍の特徴に合わせた治療を提供することができます。高度な画像診断と治療計画技術により、腫瘍医は腫瘍の位置、大きさ、形状に基づいた個別の粒子線治療プロトコルを開発することができます。このような個別化によって治療効果が向上し、患者が不必要な被ばくをすることなく必要な量の放射線を正確に受けることができるため、リソースの使用が最適化されます。ヘルスケア・システムにとっては、オーダーメイドの治療が可能になることで、患者の満足度と治療成績が向上し、包括的ながん治療プログラムの一環として粒子線治療の価値が高まります。生活の質の向上、長期的なコストの削減、高精度がん治療のサポートなど、粒子線治療が患者やヘルスケアプロバイダーにもたらす変革の可能性は計り知れません。

粒子線治療市場の成長を促進しているものは？

粒子線治療市場の成長は、がん罹患率の上昇、低侵襲で精密ながん治療に対する需要の増加、粒子線治療技術の進歩、陽子線および炭素イオン治療センターへのアクセス拡大などの要因によってもたらされます。がんの罹患率が世界的に上昇を続ける中、副作用を最小限に抑えながら治療成績を向上させる高度な治療オプションが急務となっています。粒子線治療は、正確なターゲティングと健康な組織への影響の低減により、従来の放射線に代わる効果的で患者に優しい治療法を提供し、この需要に応えます。この需要は、組織を温存する治療が最も必要とされる小児腫瘍学において特に強いです。世界のがん罹患率の増加に伴い、粒子線治療のような高精度治療に対する需要が市場拡大の原動力になると予想されます。

低侵襲のがん治療に対する需要の高まりが、粒子線治療市場の成長をさらに後押ししています。患者もヘルスケアプロバイダーも、より少ない副作用と短い回復時間で効果的な結果をもたらす治療を求めています。粒子線治療は、高線量の放射線を腫瘍に直接照射し、周辺組織を温存することができるため、精度と最小限の侵襲性という要求に合致しています。粒子線治療が従来の放射線よりも優れている点については、患者や医療従事者の間で認識が高まっており、採用率の上昇につながっています。患者が有効性とQOLのバランスを考慮した治療を求めるようになるにつれ、粒子線治療は複雑でリスクの高いがんに適した選択肢として台頭してきています。

また、粒子線治療の小型化、シングルルームシステムなど、粒子線治療技術の進歩も、粒子線治療をより身近で手頃なものにし、市場成長を促進しています。これらのコンパクトなシステムは、従来の粒子線治療施設に必要なインフラやコストを削減し、より多くの病院やがんセンターがこの先進技術を採用することを可能にしています。さらに、強度変調陽子線治療や適応治療計画のような技術革新は、粒子線治療の精度と適応性を高め、より幅広いがん種に対する効果を高めています。技術が向上し続けるにつれて、粒子線治療はより幅広いヘルスケア施設で利用可能となり、患者のアクセスを拡大し、市場の成長を後押ししています。

特に北米、欧州、アジア太平洋などの地域で粒子線治療センターが拡大していることも、市場成長の大きな要因となっています。各国政府やヘルスケア機関は、粒子線治療のインフラ整備に投資しており、がん治療へのメリットや長期的な医療費削減の可能性を認識しています。また、粒子線治療が患者にとってより利用しやすくなるよう、多くの国が償還や資金援助を提供しています。より多くの粒子線治療センターが世界的に設立されるにつれ、この治療法の利用可能性と認知度は高まり、さらなる需要を促進しています。がん罹患率の上昇、正確な治療に対する需要、技術の進歩、インフラの拡大といったこれらの要因が相まって、粒子線治療市場は力強い成長を遂げており、現代腫瘍学および個別化がん治療の重要な要素となっています。

セグメント

タイプ（陽子線治療、重粒子線治療）;システム（マルチルームシステム、シングルルームシステム）;用途（治療、調査）

調査対象企業の例（注目の22社）

  • Accuray Incorporated
  • Advanced Oncotherapy
  • Brainlab
  • Danfysik A/S
  • Elekta AB
  • Hitachi Ltd.
  • IBA Worldwide
  • Koninklijke Philips N.V.
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Optivus Proton Therapy Inc.
  • Panacea
  • ProTom International
  • Provision Healthcare
  • PTW Freiburg GmbH
  • SAH Global LLC
  • Shinva Medical Instrument Co. Ltd
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.
  • xstrahl

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP22463

Global Particle Therapy Market to Reach US$2.8 Billion by 2030

The global market for Particle Therapy estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Heavy Ion Therapy segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$481.4 Million While China is Forecast to Grow at 8.0% CAGR

The Particle Therapy market in the U.S. is estimated at US$481.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$432.1 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Particle Therapy Market - Key Trends & Drivers Summarized

Why Is Particle Therapy Essential in Modern Cancer Treatment?

Particle therapy has become an essential and highly effective treatment option in modern cancer care, providing precise, targeted radiation therapy with minimal damage to surrounding healthy tissue. Unlike traditional photon-based radiation, particle therapy uses charged particles like protons and carbon ions, which allow oncologists to deliver a high dose of radiation directly to tumors while sparing adjacent healthy tissues. This precision is particularly valuable in treating cancers located near critical structures, such as brain tumors, pediatric cancers, and tumors near the spinal cord, where preserving healthy tissue is crucial. As a result, particle therapy has become a cornerstone in the treatment of complex and hard-to-treat cancers, significantly improving outcomes and reducing side effects.

In addition to its accuracy, particle therapy offers a higher dose intensity at the tumor site, making it particularly effective for radioresistant tumors, which are less responsive to traditional forms of radiation. The unique properties of particle beams, such as the Bragg peak effect, allow them to release maximum energy directly at the tumor site, reducing radiation exposure beyond the tumor. This advantage minimizes side effects and long-term complications, which is especially beneficial for pediatric patients and those with cancers near sensitive organs. For patients, particle therapy means a potentially shorter treatment course with fewer complications, making it a preferred option in modern oncology for high-precision cancer care.

Moreover, particle therapy aligns with the growing trend of personalized cancer treatment, as it allows for treatment plans that are tailored to the unique characteristics of each patient’s tumor. With advancements in imaging and treatment planning, oncologists can use particle therapy to target tumors with unparalleled precision based on size, shape, and location, providing an individualized approach that improves treatment efficacy. This capability makes particle therapy an essential part of precision oncology, addressing the need for highly targeted treatments that enhance patient outcomes while reducing the physical and emotional burden of cancer treatment.

How Are Technological Advancements Enhancing Particle Therapy?

Technological advancements are significantly enhancing the effectiveness, accessibility, and efficiency of particle therapy, broadening its application and appeal in cancer treatment. One of the most significant innovations in this field is the development of intensity-modulated proton therapy (IMPT), which allows for even greater precision in dose distribution. IMPT enables oncologists to modulate the intensity of the proton beam, shaping it more accurately to match the tumor’s contours and sparing nearby healthy tissues even more effectively. This enhanced control reduces the risk of radiation-induced side effects and is particularly beneficial for complex, irregularly shaped tumors. As IMPT technology continues to advance, it offers improved outcomes for patients with challenging cancer types, increasing the overall effectiveness of particle therapy.

The integration of advanced imaging technologies, such as real-time MRI and PET scans, has further improved the accuracy of particle therapy by providing detailed, real-time images that guide treatment. These imaging technologies enable oncologists to precisely locate tumors and adjust treatment parameters to account for tumor movement, such as breathing or patient shifts, which is particularly important for tumors in the lungs or abdomen. By combining real-time imaging with particle therapy, oncologists can deliver more accurate and adaptive treatments, ensuring that radiation is consistently targeted to the tumor while sparing surrounding tissues. This innovation supports adaptive particle therapy, allowing treatment to be dynamically adjusted as the tumor changes in response to therapy, enhancing effectiveness and minimizing side effects.

The development of compact and cost-effective particle therapy systems, such as single-room proton therapy units, has increased the accessibility and affordability of particle therapy. Traditionally, particle therapy required large, complex, and expensive facilities, limiting its availability to a select number of centers worldwide. However, advancements in compact systems have made it possible for more hospitals and cancer centers to adopt particle therapy technology, making it accessible to a broader patient population. These compact systems reduce the need for large-scale infrastructure, significantly lowering costs and enabling community hospitals and regional cancer centers to offer this advanced treatment. By making particle therapy more affordable and widely available, these technological advancements are expanding its reach, providing more patients with access to high-precision cancer care.

What Are the Benefits of Particle Therapy for Patients and Healthcare Systems?

Particle therapy offers substantial benefits for both patients and healthcare systems, providing a precise, effective, and patient-friendly approach to cancer treatment. For patients, one of the primary advantages of particle therapy is its ability to minimize damage to healthy tissues, reducing both short-term and long-term side effects. This tissue-sparing property is particularly valuable for pediatric patients and those with tumors near sensitive structures, as it reduces the risk of complications and preserves quality of life. By minimizing radiation exposure to surrounding tissues, particle therapy allows patients to undergo treatment with fewer side effects, leading to a quicker recovery and enabling a better post-treatment quality of life. This advantage is especially beneficial for young patients, as it lowers the risk of secondary cancers and developmental issues associated with radiation exposure.

For healthcare systems, particle therapy reduces the long-term care costs associated with managing radiation-induced side effects and complications. Traditional radiation treatments often require extensive post-treatment care to manage side effects such as radiation dermatitis, damage to organs, and even secondary malignancies. With particle therapy’s precise targeting, the incidence of such complications is significantly reduced, leading to fewer hospital admissions and a lower demand for follow-up treatments. This reduction in post-treatment complications translates into cost savings for healthcare systems and allows resources to be allocated more effectively. By supporting better patient outcomes with fewer long-term effects, particle therapy contributes to a more sustainable approach to cancer care, which benefits healthcare systems financially and operationally.

Particle therapy also aligns well with the shift toward personalized and precision oncology, enabling healthcare providers to deliver treatments that are tailored to the unique characteristics of each patient’s tumor. With advanced imaging and treatment planning technologies, oncologists can develop individualized particle therapy protocols based on tumor location, size, and shape. This personalization enhances treatment efficacy and optimizes resource use, as patients receive precisely the amount of radiation needed without unnecessary exposure. For healthcare systems, the ability to provide tailored treatment improves patient satisfaction and outcomes, reinforcing the value of particle therapy as part of a comprehensive cancer care program. Together, these benefits—improved quality of life, reduced long-term costs, and support for precision oncology—highlight the transformative potential of particle therapy for patients and healthcare providers alike.

What Is Fueling the Growth in the Particle Therapy Market?

The growth in the particle therapy market is driven by factors such as the rising incidence of cancer, increasing demand for minimally invasive and precise cancer treatments, advancements in particle therapy technology, and expanded access to proton and carbon ion therapy centers. As cancer incidence continues to rise globally, there is an urgent demand for advanced treatment options that improve outcomes while minimizing side effects. Particle therapy, with its precise targeting and reduced impact on healthy tissues, meets this demand by providing an effective, patient-friendly alternative to traditional radiation. This demand is particularly strong in pediatric oncology, where the need for tissue-sparing therapies is paramount. As the global cancer burden grows, the demand for high-precision treatments like particle therapy is expected to drive market expansion.

The increasing demand for minimally invasive cancer treatments has further fueled growth in the particle therapy market. Patients and healthcare providers alike are seeking treatments that provide effective results with fewer side effects and shorter recovery times. Particle therapy, with its ability to deliver high-dose radiation directly to tumors while sparing surrounding tissues, aligns with this demand for precision and minimal invasiveness. The market is benefiting from a growing awareness among patients and providers about the advantages of particle therapy over traditional radiation, leading to higher adoption rates. As patients increasingly seek treatments that balance efficacy with quality of life, particle therapy is emerging as a preferred option for complex and high-risk cancers.

Advancements in particle therapy technology, such as compact and single-room systems, are also driving market growth by making particle therapy more accessible and affordable. These compact systems reduce the infrastructure and cost requirements of traditional particle therapy facilities, enabling more hospitals and cancer centers to adopt this advanced technology. Additionally, innovations like intensity-modulated proton therapy and adaptive treatment planning have enhanced the precision and adaptability of particle therapy, increasing its effectiveness across a broader range of cancer types. As technology continues to improve, particle therapy is becoming more viable for a wider range of healthcare facilities, expanding patient access and fueling market growth.

The expansion of particle therapy centers, particularly in regions like North America, Europe, and Asia-Pacific, is another significant factor in market growth. Governments and healthcare organizations are investing in particle therapy infrastructure, recognizing its benefits for cancer care and the potential for long-term healthcare cost savings. Many countries are also offering reimbursement and funding support to make particle therapy more accessible to patients. As more particle therapy centers are established globally, the availability and awareness of this treatment are increasing, driving further demand. Together, these factors—rising cancer incidence, demand for precise treatments, technological advancements, and infrastructure expansion—are driving robust growth in the particle therapy market, positioning it as a crucial component of modern oncology and personalized cancer care.

SCOPE OF STUDY:

The report analyzes the Particle Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Proton Therapy, Heavy Ion Therapy); System (Multi-Room Systems, Single-Room Systems); Application (Treatment, Research)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 22 Featured) -

  • Accuray Incorporated
  • Advanced Oncotherapy
  • Brainlab
  • Danfysik A/S
  • Elekta AB
  • Hitachi Ltd.
  • IBA Worldwide
  • Koninklijke Philips N.V.
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Optivus Proton Therapy Inc.
  • Panacea
  • ProTom International
  • Provision Healthcare
  • PTW Freiburg GmbH
  • SAH Global LLC
  • Shinva Medical Instrument Co. Ltd
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.
  • xstrahl

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Particle Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Drives Demand for Particle Therapy Solutions
    • Advancements in Proton Therapy Technologies Propel Particle Therapy Market
    • Increasing Adoption of Carbon Ion Therapy Expands Addressable Market
    • Growing Focus on Minimally Invasive Cancer Treatments Sets the Stage for Market Expansion
    • Innovations in Beam Delivery Systems Propel Particle Therapy Adoption
    • Demand for Pediatric Cancer Treatments Expands Particle Therapy Applications
    • Growing Awareness About Particle Therapy in Developing Economies Bodes Well for Market Growth
    • Increasing Use in Recurrent Tumor Treatments Sets the Stage for Market Growth
    • Demand for Proton Beam Therapy in Brain and Lung Cancers Spurs Adoption
    • Increasing Use in Proton Therapy for Prostate Cancer Sets the Stage for Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Particle Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Particle Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Particle Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Heavy Ion Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Heavy Ion Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Heavy Ion Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Multi-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Multi-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Multi-Room Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Single-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Single-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Single-Room Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Particle Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • JAPAN
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • CHINA
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • EUROPE
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Particle Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Particle Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Particle Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • FRANCE
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • GERMANY
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Italy 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 125: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of World Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of World 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of World 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of World 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030

IV. COMPETITION